LeapFrog Investments — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
MedGenomemedgenome.comin𝕏Apr 2020 · $50M
MedGenome provides genetic and molecular diagnostic testing across areas including reproductive care, rare hereditary conditions, oncology, and infectious diseases, and operates a CAP-accredited multiomics laboratory with high-throughput sequencing and a proprietary analytics platform.
BiotechDigital HealthHealthtechMedical DevicesBangalore, IN
Co-investorsNovo HoldingsSofinaATEL VenturesPeak XV Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


